- Home
- SNY vs HCA Comparison
SNY vs HCA Comparison
Compare SNY & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- HCA
- Stock Information
- Founded
- SNY 1994
- HCA 1968
- Country
- SNY France
- HCA United States
- Employees
- SNY N/A
- HCA N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- HCA Hospital/Nursing Management
- Sector
- SNY Health Care
- HCA Health Care
- Exchange
- SNY Nasdaq
- HCA Nasdaq
- Market Cap
- SNY 116.1B
- HCA 104.6B
- IPO Year
- SNY N/A
- HCA N/A
- Fundamental
- Price
- SNY $51.00
- HCA $467.04
- Analyst Decision
- SNY Buy
- HCA Buy
- Analyst Count
- SNY 4
- HCA 21
- Target Price
- SNY $61.50
- HCA $457.28
- AVG Volume (30 Days)
- SNY 3.1M
- HCA 1.4M
- Earning Date
- SNY 10-24-2025
- HCA 10-24-2025
- Dividend Yield
- SNY 3.11%
- HCA 0.62%
- EPS Growth
- SNY 105.93
- HCA 15.74
- EPS
- SNY 8.67
- HCA 25.82
- Revenue
- SNY $53,890,648,839.00
- HCA $74,372,000,000.00
- Revenue This Year
- SNY $1.40
- HCA $7.32
- Revenue Next Year
- SNY $6.67
- HCA $4.32
- P/E Ratio
- SNY $11.67
- HCA $18.12
- Revenue Growth
- SNY N/A
- HCA 6.82
- 52 Week Low
- SNY $44.62
- HCA $289.98
- 52 Week High
- SNY $60.12
- HCA $469.18
- Technical
- Relative Strength Index (RSI)
- SNY 59.74
- HCA 77.42
- Support Level
- SNY $49.62
- HCA $424.00
- Resistance Level
- SNY $52.20
- HCA $469.18
- Average True Range (ATR)
- SNY 0.66
- HCA 11.24
- MACD
- SNY 0.19
- HCA 3.80
- Stochastic Oscillator
- SNY 72.42
- HCA 96.51
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About HCA HCA Healthcare Inc.
HCA Healthcare Inc is a Nashville-based healthcare provider organization operating the collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.